Advertisement

Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs

John A. EllisDepartment of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5B4.

Search for other papers by John A. Ellis in
Current site
Google Scholar
PubMed
Close
 DVM, PhD, DACVP, DACVM
,
Deborah M. HainesDepartment of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5B4.

Search for other papers by Deborah M. Haines in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Keith H. WestDepartment of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5B4.

Search for other papers by Keith H. West in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
J. Hilty BurrPfizer Animal Health, 812 Springdale Dr, Exton, PA 19341-2803.

Search for other papers by J. Hilty Burr in
Current site
Google Scholar
PubMed
Close
 DVM
,
Arthur DaytonPfizer Animal Health, 812 Springdale Dr, Exton, PA 19341-2803.

Search for other papers by Arthur Dayton in
Current site
Google Scholar
PubMed
Close
 PhD
,
Hugh G. G. TownsendDepartment of Medicine, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5B4.

Search for other papers by Hugh G. G. Townsend in
Current site
Google Scholar
PubMed
Close
 DVM, MSc
,
Edward W. KanaraPfizer Animal Health, 812 Springdale Dr, Exton, PA 19341-2803.

Search for other papers by Edward W. Kanara in
Current site
Google Scholar
PubMed
Close
 DVM, DABVP
,
Carrie KonobyDepartment of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5B4.

Search for other papers by Carrie Konoby in
Current site
Google Scholar
PubMed
Close
 BS
,
Ann CrichlowDepartment of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5B4.

Search for other papers by Ann Crichlow in
Current site
Google Scholar
PubMed
Close
 BS
,
Karen MartinDepartment of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada S7N 5B4.

Search for other papers by Karen Martin in
Current site
Google Scholar
PubMed
Close
, and
Garland HeadrickPfizer Animal Health, 812 Springdale Dr, Exton, PA 19341-2803.

Search for other papers by Garland Headrick in
Current site
Google Scholar
PubMed
Close
 BS
View More View Less

Abstract

Objective—To determine comparative efficacy of vaccines administered IM and intranasally, used alone or sequentially, to protect puppies from infection with Bordetella bronchiseptica and determine whether systemic or mucosal antibody response correlated with protection.

Design—Randomized controlled trial.

Animals—50 specific-pathogen-free Beagle puppies.

Procedure—In 2 replicates of 25 dogs each, 14-weekold puppies that were vaccinated against canine distemper virus and parvovirus were vaccinated against B bronchiseptica via intranasal, IM, intranasal-IM, or IMintranasal administration or were unvaccinated controls. Puppies were challenge exposed via aerosol administration of B bronchiseptica 2 weeks after final vaccination. Clinical variables and systemic and mucosal antibody responses were monitored for 10 days after challenge exposure. Puppies in replicate 1 were necropsied for histologic and immunohistochemical studies.

Results—Control puppies that were seronegative before challenge exposure developed paroxysmal coughing, signs of depression, anorexia, and fever. Vaccinated puppies (either vaccine) that were seronegative before challenge exposure had fewer clinical signs. Puppies that received both vaccines had the least severe clinical signs and fewest lesions in the respiratory tract. Vaccinated dogs had significantly higher concentrations of B bronchiseptica-reactive antibodies in serum saliva before and after challenge. Antibody concentrations were negatively correlated with bacterial growth in nasal cavity and pharyngeal samples after challenge exposure.

Conclusions and Clinical Relevance—Parenterally and intranasally administered vaccines containing B bronchiseptica may provide substantial protection from clinical signs of respiratory tract disease associated with infection by this bacterium. Administration of both types of vaccines in sequence afforded the greatest degree of protection against disease. (J Am Vet Med Assoc 2001;218:367–375)

Abstract

Objective—To determine comparative efficacy of vaccines administered IM and intranasally, used alone or sequentially, to protect puppies from infection with Bordetella bronchiseptica and determine whether systemic or mucosal antibody response correlated with protection.

Design—Randomized controlled trial.

Animals—50 specific-pathogen-free Beagle puppies.

Procedure—In 2 replicates of 25 dogs each, 14-weekold puppies that were vaccinated against canine distemper virus and parvovirus were vaccinated against B bronchiseptica via intranasal, IM, intranasal-IM, or IMintranasal administration or were unvaccinated controls. Puppies were challenge exposed via aerosol administration of B bronchiseptica 2 weeks after final vaccination. Clinical variables and systemic and mucosal antibody responses were monitored for 10 days after challenge exposure. Puppies in replicate 1 were necropsied for histologic and immunohistochemical studies.

Results—Control puppies that were seronegative before challenge exposure developed paroxysmal coughing, signs of depression, anorexia, and fever. Vaccinated puppies (either vaccine) that were seronegative before challenge exposure had fewer clinical signs. Puppies that received both vaccines had the least severe clinical signs and fewest lesions in the respiratory tract. Vaccinated dogs had significantly higher concentrations of B bronchiseptica-reactive antibodies in serum saliva before and after challenge. Antibody concentrations were negatively correlated with bacterial growth in nasal cavity and pharyngeal samples after challenge exposure.

Conclusions and Clinical Relevance—Parenterally and intranasally administered vaccines containing B bronchiseptica may provide substantial protection from clinical signs of respiratory tract disease associated with infection by this bacterium. Administration of both types of vaccines in sequence afforded the greatest degree of protection against disease. (J Am Vet Med Assoc 2001;218:367–375)